Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc > Groome Watch
View:
Post by prophetoffactz on Feb 08, 2024 11:44am

Groome Watch

Cameron Groome just bought $20,000 of IFA.v.

That could be significant as IFA may be in the final stretch of receiving US EPA kill claims for apparel. Imagine clothing and bed sheets, etc., that kill infectious diseases in hospitals or old age homes, etc. 


iFabric Corp Update on Status of EPA Submission of PROTX2 Textile Application

T.IFA 

MARKHAM, ON / ACCESSWIRE / August 31, 2023 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF), today updates on the status of the submission to the USA Environmental Protection Agency (EPA).

"Ongoing communications with the United States Environmental Agency have culminated in their request for a final dataset regarding the leaching nature of textiles treated with PROTX2. Whilst we have for years internally conducted leaching testing to apparel and medical industry standards, the EPA have requested a distinct protocol that is acceptable to them," stated Hylton Karon, President and CEO of iFabric.

"The study is being carried out at an independent laboratory under Good Laboratory Practices ("GLP") standards. Our prior testing has always shown that the leaching of our product is well within the acceptable safety norms. Accordingly, I would expect the current test to yield similar results and thus be our final step in the approval process for public health claims on apparel," concluded Hylton Karon.

ABOUT iFABRIC CORP:
Headquartered in Markham, Ontario, iFabric, www.ifabriccorp.com, is listed on the TSX and, currently has 30.3 million shares issued and outstanding. Its two strategic divisions offer a variety of products and services through wholly-owned subsidiaries, namely, Intelligent Fabric Technologies (North America) Inc. ("IFTNA") and Coconut Grove Pads Inc. ("Coconut Grove").

IFTNA is focused on development and sale of high-performance sports apparel, medical protective apparel, consumer protective apparel, and proprietary treatments that provide "intelligent" properties to fabrics, foams, plastics, and numerous other surfaces, thereby improving the safety and well-being of the user. Such intelligent properties include antiviral and antibacterial characteristics, water-repellence and UV protection, among others.

Coconut Grove, operating as Coconut Grove Intimates, is a designer, manufacturer, distributor, licensor and licensee of ladies' intimate apparel products and accessories.

FORWARD-LOOKING STATEMENTS
Forward-looking statements provide an opinion as to the effect of certain events and trends on the business. Certain statements contained in this news release constitute forward-looking statements. The use of any words such as "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors, including the risk factors described in the Company's annual information form dated December 29, 2022 and other filings with the Canadian securities regulators available under the Company's profile on SEDAR at www.sedar.com.

Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made. Readers are cautioned not to place undue reliance on these statements as the Company's actual results, performance, or achievements may differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements if known or unknown risks, uncertainties or other factors affect the Company's business, or if the Company's estimates or assumptions prove inaccurate. Therefore, the Company cannot provide any assurance that forward-looking statements will materialize. The Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or any other reason except as required by applicable securities laws.

Given the impacts of COVID-19 and the war in Ukraine resulting in ongoing uncertainty, there can be no assurances regarding: (a) the COVID-19 and the war in Ukraine related impacts on the Company's business, operations and performance, (b) the Company's ability to mitigate such impacts; (c) credit, market, currency, operational, and liquidity risks generally; and (d) other risks inherent to the Company's business and/or factors beyond its control which could have a material adverse effect on the Company.

Any financial outlook or future-oriented financial information in this news release, as defined by applicable securities legislation, has been approved by management of iFabric. Such financial outlook or future-oriented financial information is provided for the purpose of providing information about management's reasonable expectations as to the anticipated results of its proposed business activities. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The forward-looking statements contained in this press release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

FOR FURTHER INFORMATION, please contact:
Hilton Price, CFO
Tel: 647.465.6161
Email: hilton.price@rogers.com
Website: www.ifabriccorp.com

Neither the TSX Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this press release.

SOURCE: iFabric Corp

Comment by RICHOFFMBX on Feb 09, 2024 4:32pm
Interesting, thank you for sharing!  iFabrc's home in Markham is only 40 minutes from MBX in Mississauga...wonder if Cameron and friends know people there?
Comment by Method on Feb 09, 2024 8:36pm
He's on the Board
Comment by mercedesman on Feb 09, 2024 10:10pm
Not always prescient with his IFA. Purchases  in 2021 he purchased 5000 shares at $3.90 ( his only other transaction other than option grants)  For almost the same dollar on his recent purchase, his outlay back then ( about $20k), only netted him about a 1/4 as many shares. Is he averaging down with good reason ?  Maybe. But the options granted along the way have been ...more  
Comment by prophetoffactz on Feb 09, 2024 10:41pm
"Is he averaging down with good reason ?  Maybe. But the options granted along the way have been anything but rewarding."  IFA.to has had an unexpectedly long, long road with the US EPA getting its kill claims. It looks like we are now at the final hurdle for breakthrough kill claims. Groome is buying at this very interesting moment. The kill claims could make IFA.to ...more  
Comment by wizzdumb on Feb 09, 2024 10:46pm
Could you please take your IFA discussion to that board. Thanks. 
Comment by mercedesman on Feb 10, 2024 9:26pm
Just wanted to dispel the notion that everything Groome gets involved with, necessarily turns to gold.  Having said that I personally like what he is doing and has done for MBX.  I wish IFA well in the future and agree further discussion on the subject belongs elsewhere.  The common thread (Groome) does not, in and of itself, indicate that MBX will succeed.  MM
Comment by rjc7 on Feb 11, 2024 9:54am
I'm all in on that. Well said.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities